ANDA 62497, held by Teva. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 62497 (Doxy-Lemmon), held by Teva, was first approved by FDA on Aug 23, 1984, with 13 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 23, 1984 | Original application | Approved | None posted |
| Doxy-LemmonEQ 50MG BASE · capsule;oral | Doxycycline Hyclate | Discontinued |
| Doxy-LemmonEQ 100MG BASE · capsule;oral | Doxycycline Hyclate | Discontinued |
| May 19, 2014 | Supplement 24Labeling · Standard review | Approved | None posted |
| Aug 30, 2001 | Supplement 23Manufacturing | Approved | None posted |
| Jun 23, 1994 | Supplement 19Manufacturing | Approved | None posted |
| Jun 23, 1994 | Supplement 18Manufacturing | Approved | None posted |
| Jun 23, 1994 | Supplement 17Manufacturing | Approved | None posted |
| Jan 26, 1994 | Supplement 22Manufacturing | Approved | None posted |
| Jan 26, 1994 | Supplement 21Manufacturing | Approved | None posted |
| Jan 26, 1994 | Supplement 20Manufacturing | Approved | None posted |
| Apr 1, 1993 | Supplement 16Manufacturing | Approved | None posted |
| Mar 26, 1992 | Supplement 14Labeling | Approved | None posted |
| Oct 3, 1990 | Supplement 13Manufacturing | Approved | None posted |
| May 3, 1988 | Supplement 12Manufacturing | Approved | None posted |
| Nov 9, 1987 | Supplement 11Manufacturing | Approved | None posted |
| Aug 23, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters